BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 11488250)

  • 1. [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature].
    Mann SC; Auriacombe M; Macfadden W; Caroff SN; Cabrina Campbell E; Tignol J
    Encephale; 2001; 27(3):213-6. PubMed ID: 11488250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic difficulties and efficacy of electroconvulsive therapy in the treatment of lethal catatonia].
    Turczyński J
    Psychiatr Pol; 1993; 27(5):535-43. PubMed ID: 7902992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G; Susman VL
    J Clin Psychiatry; 1987 Mar; 48(3):102-5. PubMed ID: 2880837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].
    Terlikowska M; Marzański M
    Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A; Lesch KP
    Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
    J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are catatonia and neuroleptic malignant syndrome related conditions?].
    Vesperini S; Papetti F; Pringuey D
    Encephale; 2010 Apr; 36(2):105-10. PubMed ID: 20434626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catatonia, malignant neuroleptic syndrome and myositis ossificans].
    Topka H; Buchkremer G
    Nervenarzt; 1996 May; 67(5):413-7. PubMed ID: 9005354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L; Oepen G
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
    Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E
    Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catatonia: resurgence of a concept. A review of the international literature].
    Pommepuy N; Januel D
    Encephale; 2002; 28(6 Pt 1):481-92. PubMed ID: 12506260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive therapy for catatonia secondary to neuroleptic malignant syndrome in a patient with multiple sclerosis.
    Harley JA; Peebles C; Porter RJ
    Aust N Z J Psychiatry; 2019 Jul; 53(7):703-704. PubMed ID: 31072113
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome.
    Am J Psychiatry; 1989 Sep; 146(9):1240-2. PubMed ID: 2569842
    [No Abstract]   [Full Text] [Related]  

  • 15. Residual catatonic state following neuroleptic malignant syndrome.
    Caroff SN; Mann SC; Keck PE; Francis A
    J Clin Psychopharmacol; 2000 Apr; 20(2):257-9. PubMed ID: 10770467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of 34 catatonic patients: analysis of clinical care and treatment.
    Tuerlings JH; van Waarde JA; Verwey B
    Gen Hosp Psychiatry; 2010; 32(6):631-5. PubMed ID: 21112456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome and its controversies.
    Margetić B; Aukst-Margetić B
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECT in the neuroleptic malignant syndrome: case report.
    Jessee SS; Anderson GF
    J Clin Psychiatry; 1983 May; 44(5):186-8. PubMed ID: 6133848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome and related conditions].
    Amore M; Montanari M
    Minerva Psichiatr; 1992; 33(4):259-83. PubMed ID: 1363674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for neuroleptic malignant syndrome.
    Francis A; Chandragiri S; Petrides G
    Am J Psychiatry; 1998 Nov; 155(11):1639-40. PubMed ID: 9812151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.